previous  12  next  · entire list

Donald Rumsfeld makes $5m killing on bird flu drug
2006-03-12, Independent (one of the UK's leading newspapers)
http://news.independent.co.uk/world/americas/article350787.ece

The US Defence Secretary has made more than $5m (£2.9m) in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu, the drug being bought in massive amounts by Governments to treat a possible human pandemic of the disease. More than 60 countries have so far ordered large stocks of the antiviral medication - the only oral medicine believed to be effective against the deadly H5N1 strain of the disease - to try to protect their people. The United Nations estimates that a pandemic could kill 150 million people worldwide. The drug was developed by a Californian biotech company, Gilead Sciences. Mr Rumsfeld was on the board of Gilead from 1988 to 2001, and was its chairman from 1997. He then left to join the Bush administration, but retained a huge shareholding. The 2005 report showed that, in all, he owned shares worth up to $95.9m, from which he got an income of up to $13m. The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year.

Note: If the above link fails, click here. For many more strange coincidences and facts around the avian flu scare, take a look at our summary of eye-opening news articles available here.

Tamiflu Developer: Swine Flu Could Have Come From Bio-Experiment Lab
2009-05-14, ABC News
http://abcnews.go.com/GMA/SwineFlu/story?id=7584420

An Australian researcher claims the swine flu, which has killed at least 64 people so far, might not be a mutation that occurred naturally but a man-made product of genetic experiments accidently leaked from a laboratory -- a theory the World Health Organization is taking very seriously. Adrian Gibbs, a scientist on the team that was behind the development of Tamiflu, says in a report he is submitting today that swine flu might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public. "It might be some sort of simple error that's not being recognized," Gibbs said on ABC's "Good Morning America." In an interview with Bloomberg Television, Gibbs admitted there are other ways to explain swine flu's origin. "One of the simplest explanations if that it's a laboratory escape, but there are lots of others," he said. Regardless of the validity of Gibb's claims, he and several experts say that just bringing the idea of laboratory security to the public's attention is important. "There are lives at risk," Gibbs said. "The sooner this idea gets out, the better."

Note: What would cause one of the developers of Tamiflu to make such a statement? If you read between the lines, there is much more here than meets the eye. For lots more on this intriguing development, click here.

Some see media flu coverage as overblown
2009-05-03, San Francisco Chronicle
http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2009/05/03/MN3B17CKP7.DTL

After a few days of breathless H1N1 flu coverage - some of it on his own network - CNN commentator Jack Cafferty noted that 13,000 people have died from the "regular ol' flu" this year in the United States, compared with just one confirmed H1N1 flu death. Cafferty then asked his audience to respond to his online poll asking "if swine flu coverage was overblown." He waited a moment, then said, "Hint: Yes." For a week, the flu story has whet cable TV's bloodlust with what the 24-hour cable news vacuum craves: mystery, death and great visuals that inspire fear. "Frankly, I've been a little horrified by how sensationalist and scare-mongering it is," said Vivian Schiller, chief executive officer of National Public Radio. No detail about the flu - often delivered without context - has been too tiny to go unreported, which means that cable TV viewers are getting coverage that is moment-to-moment but often not terribly useful. Conservative talk radio hosts have used fear about the flu to segue to anti-immigrant remarks and calls to close the U.S.-Mexico border.Just when the coverage appeared to be calming a bit Thursday, Vice President Joe Biden helped rekindle fears by saying on the "Today'" show that he "would tell members of my family - and I have - I wouldn't go anywhere in confined places now." Health stories always attract huge audiences, said Andrew Kohut, president of the Pew Research Center. But viewers shouldn't expect as much breathless coverage when Congress begins debating an overhaul of the U.S. health care system over the next few months.

Note: For an excellent article showing how media fear-mongering of this and past flu emergencies have brought unprecedented profits to the pharmaceutical companies, click here.

Doctor says bird flu drug is ‘useless’
2005-12-04, London Times
http://www.timesonline.co.uk/article/0,,2091-1903144,00.html

A Vietnamese doctor who has treated dozens of victims of avian flu claims the drug being stockpiled around the world to combat a pandemic is 'useless' against the virus. Dr Nguyen Tuong Van runs the intensive care unit at the Centre for Tropical Diseases in Hanoi and has treated 41 victims of H5N1. Van followed World Health Organisation (WHO) guidelines and gave her patients Tamiflu, but concluded it had no effect. 'We place no importance on using this drug on our patients,' she said. 'Tamiflu is really only meant for treating ordinary type A flu. It was not designed to combat H5N1 . . . (Tamiflu) is useless.' Roche, the company that makes Tamiflu, has sold stockpiles of the drug to 40 countries and insists there is clear evidence it will protect against a future flu virus. However, it stresses the drug must be given within 48 hours to be effective. The WHO admitted Tamiflu had not been widely successful in humans. 'However, we believe in many Asian countries it hasn't been used until late in the illness,' a spokesman said.

Note: Yet hundreds of millions of dollars are being spent to stockpile this drug. It's quite interesting that the former chairman of the board of directors of the company that made Tamiflu is current Secretary of Defense Donald Rumsfeld. Mr. Rumsfeld has had over $5 million in stock gains from the sales of this drug. To read about this and lots more: http://www.WantToKnow.info/avianflu

How Serious Is the Risk of Avian Flu?
2006-03-27, New York Times
http://www.nytimes.com/2006/03/27/health/28qna.html?ex=1301202000&en=ce4ccbd2...

A human pandemic caused by A(H5N1) is by no means inevitable. Many researchers doubt it will ever happen. The virus does not infect people easily, and those who do contract it almost never spread it to other humans. Bird flu is what the name implies: mostly an avian disease. It has infected tens of millions of birds but fewer than 200 people, and nearly all of them have caught it from birds. But when A(H5N1) does get into people, it can be deadly. It has killed more than half of its known human victims -- an extraordinarily high rate. The virus lacks just one trait that could turn it into a pandemic: transmissibility. Everything hangs on transmissibility. But it is impossible to predict whether A(H5N1) will become contagious among people. Most bird flu viruses do not jump species to people. Some experts say that since A(H5N1) has been around for at least 10 years and the shift has not occurred, it is unlikely to happen. Others refuse to take that bet. The best protection in any flu pandemic will come from a vaccine, but scientists cannot tell ahead of time what strain the vaccine should protect against. There is no assurance that the next pandemic will even involve A(H5N1). It may involve a different strain of bird flu, and an A(H5N1) vaccine would not work for it.

Note: Many thanks to the Times for this rare article which largely dispels fears rather than increasing them. For more excellent information on the avian flu, see http://www.WantToKnow.info/avianflu

Selling 'pandemic flu' through a language of fear
2006-03-21, Christian Science Monitor
http://www.csmonitor.com/2006/0321/p09s01-coop.html

Americans consider the United States to be a country where debate flourishes. Yet with regard to avian flu, hyped sound bites predominate. When President Bush asked Congress for $7.1 billion toward "pandemic flu preparedness," even his critics replied "not enough." What is lacking in the overall discussion about pandemic flu is disagreement, criticism, and skepticism - once the bedrock of science - from researchers willing to question and test the data. Some facts: According to the World Health Organization, the first "outbreak" of the H5N1 virus, also known as avian flu, killed six people in 1997. Since then, H5N1 has allegedly killed 97 more worldwide, the majority of whom lived in poor, rural areas and had direct contact with dead or sick birds often kept in unsanitary conditions. These numbers do not suggest the human population faces an insurmountable threat from this virus. Peter Palese, flu scientist at Mount Sinai School of Medicine in New York, told The New York Times in a Nov. 8, 2005 article that H5N1 is a false alarm. The virus has been "around for more than a dozen years, but it hasn't jumped into the human population." The reason? It probably can't. There are better ways to promote America's health than selling sickness through the language of fear. Before the government employs "all instruments of national power," including "quarantine authority," as the National Strategy for Pandemic Influenza declares, we need to be told what "pandemic flu" really means.

Note: Not mentioned are the huge profits reaped by the drug companies and their political supporters thanks to the intense fear of bird flu generated by the media. For more: http://www.WantToKnow.info/healthcoverup

Bird Flu Victims Die ... After Becoming Resistant to Tamiflu
2005-12-22, CBS/Associated Press
http://www.cbsnews.com/stories/2005/12/21/health/main1156563.shtml

In a development health experts are calling alarming, two bird flu patients in Vietnam died after developing resistance to Tamiflu, the key drug that governments are stockpiling in case of a large-scale outbreak. The experts said the deaths were disturbing because the two girls had received early and aggressive treatment with Tamiflu and had gotten the recommended doses. Since 2003, avian flu has killed about 70 people, mostly in Vietnam and Thailand, and nearly all involved close contact with infected birds. Health experts fear the virus could morph into a form that spreads easily between people. The new report involved eight Vietnamese bird flu patients given Tamiflu upon being hospitalized in 2004 or 2005. Half of the patients died. Lab tests showed two of those who died...had developed resistance.

Note: If the above link fails, click here.

Rumsfeld's growing stake in Tamiflu
2005-10-31, CNN
http://money.cnn.com/2005/10/31/news/newsmakers/fortune_rumsfeld/

The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu. Rumsfeld served as Gilead (Research)'s chairman from 1997 until he joined the Bush administration in 2001, and he still holds a Gilead stake valued at between $5 million and $25 million. In the past six months fears of a pandemic and the ensuing scramble for Tamiflu have sent Gilead's stock from $35 to $47. That's made the Pentagon chief, already one of the wealthiest members of the Bush cabinet, at least $1 million richer. Rumsfeld isn't the only political heavyweight benefiting from demand for Tamiflu. Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead since the beginning of 2005.

Man with tuberculosis jailed for not wearing mask
2007-04-03, CNN/Associated Press
http://www.cnn.com/2007/HEALTH/conditions/04/03/tuberculosis.confinement.ap

Behind the county hospital's tall cinderblock walls, a 27-year-old tuberculosis patient ... sits in a jail cell equipped with a ventilation system that keeps germs from escaping. Robert Daniels has been locked up indefinitely, perhaps for the rest of his life, since last July. But he has not been charged with a crime. Instead, he suffers from an extensively drug-resistant strain of tuberculosis. It is considered virtually untreatable. County health authorities obtained a court order to lock him up as a danger to the public because ... he did not heed doctors' instructions to wear a mask in public. "I'm being treated worse than an inmate," Daniels said. "I'm all alone. Four walls. Even the door to my room has been locked. I haven't seen my reflection in months." He said sheriff's deputies will not let him take a shower -- he cleans himself with wet wipes -- and have taken away his television, radio, personal phone and computer. His only visitors are masked medical staff members who come in to give him his medication. Though Daniels' confinement is extremely rare, health experts say it is a situation that U.S. public health officials may have to confront more and more because of the spread of drug-resistant TB and the emergence of diseases such as SARS and avian flu.

Note: If the above link fails, click here. Are we being prepared for mass quarantines and imprisonment due to disease? For more, click here.

U.S. signs deal to stockpile anti-bird-flu drug
2006-07-01, San Francisco Chronicle
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/07/01/MNGDMJNKP21.DTL&h...

Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.

Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu

Remember Anthrax?
2005-11-02, Newsweek
http://msnbc.msn.com/id/9900947/site/newsweek

Just as President George W. Bush is launching an ambitious plan to guard against an avian flu pandemic, an administration program to prepare for a potential anthrax attack is running into new and unexpected hurdles. VaxGen Inc., a California biotech firm that last year was awarded an $877.5 million contract to supply a newly invented, and so far unlicensed, anthrax vaccine, acknowledged this week that it won't begin to start deliveries to the federal government until the latter part of next year -- six months later than it originally intended. For months, investigators on both sides of the aisle have expressed concerns that the administration may have invested too big a chunk of the nation's biodefenses in one obscure and relatively untested company. Last year's decision by HHS to award the contract to the little-known VaxGen is being scrutinized by at least two congressional committees. The company's product will have to pass more large-scale tests proving its safety and effectiveness on people before it is fully licensed by the Food and Drug Administration for use on humans, and company officials say they do not expect it to be fully licensed at least until 2007. A New York Times report last December noted that...the company had faced lawsuits filed by investors who claimed VaxGen misinformed them about an AIDS vaccine that the company had heavily promoted but which later failed to work.

Note: For more on how greed and corruption in the pharmaceutical industry affects your health and wallet, see our Health Information Center.

Companies look to Swine Flu to drive profits
2009-04-29, ABC News
http://abclocal.go.com/wjrt/story?section=news/national_world&id=6786340

Pharmaceutical stocks are skyrocketing on fears that a swine flu outbreak could go global. Manufacturers of antiviral drugs [and] companies gearing up to produce a vaccine ... are turning profits in an otherwise skittish and down market. Companies gearing up for swine flu, including Roche, Gilead Sciences and GlaxoSmithKline, the manufacturers of the leading antiviral flu medications, are best positioned to see a boost in profits if the disease escalates to epidemic proportions, analysts said. Tamiflu ... was developed by Gilead and manufactured by Roche. Both companies' share prices spiked soon after the U.S. government allowed for its stockpiles of the drug to be made publicly available. Gilead stock surged to $47.53 at the end of the day Monday, up 3.78 percent. Roche rose to $31.72, up 4.34 percent. The other major flu drug currently on the market is Relenza, also stockpiled and released by the government, and manufactured by GlaxoSmithKline. Shares of Glaxo closed surged Monday to $31.56, up 7.57 percent. Both Tamiflu and Relenza are stockpiled by governments and in the case of an outbreak the companies are often required to sell the drugs directly to the government at a discount. "Government stockpiling is viewed as boon for profits. Though the government gets a discount and the margins sold to the government are lower than those if they sold to Walgreens, from a stock perspective it's an unexpected positive surprise," he said.

Note: Pharmaceutical companies make big bucks from scares like the avian flu and swine flu. Yet are the recommended drugs really effective? Many studies say they are not. For analysis of profiteering by the pharmaceutical industry during a previous flu scare, click here. See this link for lots more.

How to Deal with Swine Flu: Heeding the Mistakes of 1976
2009-04-27, Time Magazine
http://www.time.com/time/health/article/0,8599,1894129,00.html

In February 1976, an outbreak of swine flu struck Fort Dix Army base in New Jersey, killing a 19-year-old private and infecting hundreds of soldiers. Concerned that the U.S. was on the verge of a devastating epidemic, President Gerald Ford ordered a nationwide vaccination program at a cost of $135 million (some $500 million in today's money). Within weeks, reports surfaced of people developing Guillain-Barré syndrome, a paralyzing nerve disease that can be caused by the vaccine. By April, more than 30 people had died of the condition. Facing protests, federal officials abruptly canceled the program on Dec. 16. The epidemic failed to materialize. Medical historians and epidemiologists say ... the decisions made in the wake of the '76 outbreak — and the public's response to them — provide a cautionary tale for public health officials, who may soon have to consider whether to institute draconian measures to combat the disease. "I think 1976 provides an example of how not to handle a flu outbreak," says Hugh Pennington, an emeritus professor of virology at Britain's University of Aberdeen. Despite modern advances in microbiology, today's health officials still make decisions in a "cloud of uncertainty," Pennington says. "At the moment, our understanding of the current outbreak is similarly limited. For example, we don't yet understand why people are dying in Mexico but not elsewhere." Howard Markel, director of the Center for the History of Medicine at the University of Michigan and a historical consultant to the CDC on flu pandemics, says the most vexing decision facing health officials is when to institute mass vaccination programs.

Note: To watch two short commercials made in 1976 showing clear scare tactics, click here. Only one person died from the actual flu in this 1976 "epidemic," yet more than 30 died of the flu vaccine. To explore the serious risks of vaccines reported in the media, click here. For lots more on bird and swine flu scares, click here.

Baxter: Product contained live bird flu virus
2009-02-27, Toronto Sun
http://www.torontosun.com/news/canada/2009/02/27/8560781.html

The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses. And an official of the World Health Organization's European operation said the body is closely monitoring the investigation into the events that took place at Baxter International's research facility in Orth-Donau, Austria. The contaminated product, a mix of H3N2 seasonal flu viruses and unlabelled H5N1 viruses, was supplied to an Austrian research company. The Austrian firm, Avir Green Hills Biotechnology, then sent portions of it to sub-contractors in the Czech Republic, Slovenia and Germany. The contamination incident, which is being investigated by the four European countries, came to light when the subcontractor in the Czech Republic inoculated ferrets with the product and they died. Ferrets shouldn't die from exposure to human H3N2 flu viruses. Public health authorities concerned about what has been described as a "serious error" on Baxter's part have assumed the death of the ferrets meant the H5N1 virus in the product was live. But the company, Baxter International Inc., has been parsimonious about the amount of information it has released about the event. On Friday, the company's director of global bioscience communications confirmed what scientists have suspected. "It was live," Christopher Bona said in an email. Accidental release of a mixture of live H5N1 and H3N2 viruses could have resulted in dire consequences.

Note: How on earth did the avian flu virus ever get into vaccines? Could it be that this was planned? For a powerful book by a Harvard-trained dentist suggesting there may be a hidden force behind the spread of deadly infectious diseases, click here. For more revealing reports on bird flu, click here.

Bird flu drug probe after 18 teenage deaths in Japan
2007-03-01, Sydney Morning Herald (Australia's leading newspaper)
http://www.smh.com.au/news/health/bird-flu-vaccine-linked-to-18-teenage-suici...

Japanese health authorities are investigating a flu medicine that is also available in Australia after a teenager jumped 11 storeys to his death after taking the drug. It was the 18th juvenile fatality linked to Tamiflu in 17 months. The Ministry of Health, Labour and Welfare has asked the Japanese importer of Tamiflu, an anti-viral drug regarded as the most important shield against bird flu in humans, to collect information about the conditions of patients who take the drug. The 14-year-old boy's death follows a similar case two weeks ago, when a girl also 14, died after jumping from an apartment building at Gamagori, in central Japan. It also comes after a warning by the US Food and Drug Administration late last year about the dangers of giving children Tamiflu. The drug is being stockpiled in Australia as the first line of defence against bird flu. In Australia, as in Japan, it is only available by prescription. Drug companies reported that 54 people using Tamiflu died in Japan before November, the ministry said.

Note: Tamiflu is the vaccine on which Donald Rumsfeld profited $5 million and on which the U.S. government has spent hundreds of millions of dollars stockpiling, even though it might not work. For more, click here.

Major Flu Strain Found Resistant to Leading Drug, Puzzling Scientists
2009-01-09, New York Times
http://www.nytimes.com/2009/01/09/health/09flu.html?partner=rss&emc=rss&pagew...

Virtually all the dominant strain of flu in the United States this season is resistant to the leading antiviral drug Tamiflu, and scientists and health officials are trying to figure out why. The problem is not yet a public health crisis because this has been a below-average flu season so far, and because the Tamiflu-resistant strain, one of three circulating, is still susceptible to other drugs. But infectious disease specialists are worried nonetheless. Last winter, about 11 percent of the throat swabs from patients with the most common type of flu that were sent to the Centers for Disease Control and Prevention for genetic typing showed a Tamiflu-resistant strain. This season, 99 percent do. “It’s quite shocking,” said Dr. Kent A. Sepkowitz, director of infection control at Memorial Sloan-Kettering Cancer Center in New York. “We’ve never lost an antimicrobial this fast. It blew me away.” The single mutation that creates Tamiflu resistance appears to be spontaneous, and not a reaction to overuse of the drug. Complicating the problem, antiviral drugs work only if taken within the first 48 hours of infection.

Note: Isn't Tamiflu the same drug that was, according the the U.K.'s respected Independent, "bought in massive amounts by Governments to treat a possible human pandemic of the disease [avian flu]," and from which Donald Rumsfeld "made more than $5m in capital gains from selling shares"? What ever happened to all the panic about the avian flu? Could it be that it was only fear mongering? For reliable information on this key topic, click here.

Experts dismiss scare over bird flu
2005-11-01, Gainesville Sun
http://www.gainesville.com/apps/pbcs.dll/article?AID=/20051101/LOCAL/51101021...

[Gary] Butcher has been an extension veterinarian at the University of Florida's College of Veterinary Medicine since 1988. He was trained as a veterinarian specializing in avian diseases, and has a Ph.D. in poultry virology. Butcher begins his presentation with a slide that shows a "news flash" from the British press agency Reuters reporting that avian flu "poses the single biggest threat to the world right now." So far, however...no one has yet been proven to have given avian influenza to someone else. "The emphasis of all my work has changed to dealing with this madness," Butcher said Friday. "Realistically, avian influenza is not a threat to people, but everywhere you go, it has turned into a circus." Millions of chickens and waterfowl have been slaughtered in Asia...but Butcher said that of the billions of people who have probably been exposed, only about 120 have been reported to have fallen ill with avian flu. They were people who worked closely with chickens and came into contact with the birds' blood and feces. Not all health officials are sounding a warning about avian influenza, either. Dr. Marc Siegel, a practicing internist and associate professor of medicine at the New York University School of Medicine...isn't buying into the scare scenario. "If anything is contagious right now, it's judgment clouded by fear," Siegel said. [Butcher] said that although there is a potential that the virus could mutate, as it exists, it could not become an important disease in humans. "For it to become dangerous to humans, it has to go through a pretty significant genetic change. If you put this in perspective, it's not going to happen.

Note: When major corruption threatens to be exposed, those threatened know that by creating massive fear (such as a global pandemic), they can divert attention and keep money flowing into corrupt coffers. For more on this, click here and here.

Scientists see this flu strain as relatively mild
2009-04-30, Los Angeles Times
http://www.latimes.com/features/health/la-sci-swine-reality30-2009apr30,0,360...

As the World Health Organization raised its infectious disease alert level Wednesday and health officials confirmed the first death linked to swine flu inside U.S. borders, scientists studying the virus are coming to the consensus that this hybrid strain of influenza -- at least in its current form -- isn't shaping up to be as fatal as the strains that caused some previous pandemics. In fact, the current outbreak of the H1N1 virus, which emerged in San Diego and southern Mexico late last month, may not even do as much damage as the run-of-the-mill flu outbreaks that occur each winter without much fanfare. "Let's not lose track of the fact that the normal seasonal influenza is a huge public health problem that kills tens of thousands of people in the U.S. alone and hundreds of thousands around the world," said Dr. Christopher Olsen, a molecular virologist who studies swine flu at the University of Wisconsin School of Veterinary Medicine in Madison. Flu viruses are known to be notoriously unpredictable, and this strain could mutate at any point -- becoming either more benign or dangerously severe. But mounting preliminary evidence from genetics labs, epidemiology models and simple mathematics suggests that the worst-case scenarios are likely to be avoided in the current outbreak. "This virus doesn't have anywhere near the capacity to kill like the 1918 virus," which claimed an estimated 50 million victims worldwide, said Richard Webby, a leading influenza virologist at St. Jude Children's Research Hospital in Memphis, Tenn.

Note: For lots more on bird and swine flu scares, click here.

Bird flu vaccine recommended
2007-02-28, Los Angeles Times
http://www.latimes.com/news/nationworld/nation/la-sci-birdflu28feb28,1,454874...

A federal advisory committee on Tuesday recommended approval of the first bird flu vaccine for humans, despite concerns about its safety and evidence that the shots won't protect most people. The panel said although the vaccine had significant shortcomings, it was safe and effective for use during a pandemic or in high-risk situations, such as military deployment to regions facing an outbreak. The government plans to buy and stockpile enough doses for 20 million people. [The] director of the FDA's vaccine office told the panel that the vaccine was a stopgap measure. "There are numerous vaccines under development that are potentially better than this one," he said. The bird flu strain known as H5N1 originated in Asia. Although it rarely infects people, experts fear a mutation could make it easily transmissible, triggering a pandemic. From the start of 2003, 167 people, mostly in Asia, have died of the virus, according to the World Health Organization. In clinical trials, a two-shot series of the Sanofi vaccine provided protection in 45% of adults who received the highest dose, according to an FDA analysis this week. No serious side effects were detected among the 450 healthy adults who participated in a clinical test. However, some panel members were concerned that the trial was too small to reveal rare side effects. Some experts also worried about possible allergic reactions to the vaccine because it requires a massive dose — 12 times that of the seasonal inoculation.

Note: Who pays for and who profits from the purchase of these 20 million vaccine doses? It's pretty clear that the taxpayer covers the costs and the big drug companies make huge profits. Fear is quite useful for driving up profits. For lots more on profiteering from the avian flu, click here.

Hunt for New Flu: Looking for Bugs in All the Wrong Places
2005-11-08, New York Times
http://www.nytimes.com/2005/11/08/science/08flu.html?ex=1289106000&en=8c0ba3f...

Researchers...scratch their heads over the weird genetic sequence of the 1918 flu virus. Dr. Jeffery Taubenberger, a molecular pathologist at the Armed Forces Institute of Technology [said that] the 1918 virus appears to be a bird flu virus. But if it is from a bird, it is not a bird anyone has studied before. It is not like the A(H5N1) strain of bird flus in Asia, which has sickened at least 116 people, and killed 60. It is not like the influenza viruses that infect fowl in North America. Yet many researchers believe that the 1918 virus, which caused the worst infectious disease epidemic in human history, is a bird flu virus. And if so, it is the only one that has ever been known to cause a human pandemic. That, Dr. Taubenberger said, gives rise to a question. Are scientists looking for the next pandemic flu virus in all the wrong places? Birds, Dr. Slemons said, do not have much of an immune response to influenza, and so there is no particular pressure for the virus to mutate. He said birds are chronically infected with lots of flu viruses at once, and all the viruses coexist peacefully. Some experts like Dr. Peter Palese of the Mount Sinai School of Medicine in New York say the A(H5N1) flu viruses are a false alarm. He notes that studies of serum collected in 1992 from people in rural China indicated that millions of people there had antibodies to the A(H5N1) strain. That means they had been infected with an H5N1 bird virus and recovered. Despite that, and the fact that those viruses have been circulating in China more than a dozen years, almost no human-to-human spread has occurred. "The virus has been around for more than a dozen years, but it hasn't jumped into the human population," Dr. Palese said. "I don't think it has the capability of doing it."

previous

12

next

· entire list

Recommend to: